PharmaShots | Incisive News in 3 Shots

Subscribe Now

mAB

Celltrion Launch P-III Post-Exposure Prophylaxis Clinical Trial of CT-P59 for COVID-19

Celltrion Launch P-III Post-Exposure Prophylaxis Clinical Trial of CT-P59 for COVID-19

October 14, 2020

Merck's Keytruda (pembrolizumab) Receives EU Approval for Resected Stage III Melanoma in Adults

Merck's Keytruda (pembrolizumab) Receives EU Approval for Resected Stage III Melanoma in Adults

December 18, 2018

Celltrion's Truxima (rituximab-abbs) Receives FDA's Approval for Three on-Hodgkin's Lymphoma Indications

Celltrion's Truxima (rituximab-abbs) Receives FDA's Approval for Three on-Hodgkin's Lymphoma Indications

November 25, 2018

AstraZeneca Reports Results of Imfinzi (durvalumab) & Tremelimumab in Global P-III MYSTIC Trial for Stage IV Non-Small Cell Lung Cancer (NSCLC)

AstraZeneca Reports Results of Imfinzi (durvalumab) & Tremelimumab in Global P-III MYSTIC Trial for Stage IV Non-Small Cell Lu...

November 19, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us